New England Biolabs Revenue and Competitors

Ipswich, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • New England Biolabs's estimated annual revenue is currently $135.6M per year.(i)
  • New England Biolabs's estimated revenue per employee is $155,000

Employee Data

  • New England Biolabs has 875 Employees.(i)
  • New England Biolabs grew their employee count by 4% last year.

New England Biolabs's People

NameTitleEmail/Phone
1
Founder, CEO & ChairmanReveal Email/Phone
2
Chief Scientific OfficerReveal Email/Phone
3
Executive Director Marketing & SalesReveal Email/Phone
4
CFOReveal Email/Phone
5
CEOReveal Email/Phone
6
Chief IP counselReveal Email/Phone
7
CEO Reveal Email/Phone
8
Head Bioinformatics and Computational BiologyReveal Email/Phone
9
General CounselReveal Email/Phone
10
Associate DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is New England Biolabs?

Established in the mid 1970's, New England Biolabs, Inc. (NEB) is the industry leader in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next generation sequencing, synthetic biology, glycobiology, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors, including molecular diagnostics development. New England Biolabs is a privately held company, headquartered in Ipswich, MA, and has extensive worldwide distribution through a network of exclusive distributors, agents and seven subsidiaries located in Canada, China, France, Germany, Japan, Singapore and the UK. For more information about New England Biolabs visit www.neb.com. Visit us on Youtube for protocol and product videos: youtube.com/nebiolabs Follow us on Twitter: twitter.com/#!/nebiolabs

keywords:Biotechnology,Healthcare

N/A

Total Funding

875

Number of Employees

$135.6M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

New England Biolabs News

2022-04-20 - Cell-based Assay Market With Complete SWOT Analysis by ...

New England Biolabs, Inc. Cisbio Bioassays. The global cell-based assay market accounted for $3,625 million in 2016, and is anticipated to reach...

2022-04-19 - Glycomics / Glycobiology Kits Market Size 2022-2030| Key ...

New England Biolabs; Shimadzu Corporation; S-BIO; Merck KGaA; Asparia Glycomics; Agilent Technologies; Thermo Fisher Scientific. Glycomics / Glycobiology Kits...

2022-04-19 - Molecular Biology Enzymes And Kits And Reagents Market ...

Merck KGaA, Qiagen N.V, New England Biolabs, Thermo Fischer Scientific, Bio Basic Inc., Takara Bio Inc., Illumina, Jena Bioscience GmbH,...

2021-06-10 - New England Biolabs®, Inc. Launches Primer Monitor Tool for Tracking SARS-CoV-2 Variants That May Impact Primers Used in Diagnostic Assays

IPSWICH, Mass., June 10, 2021 /PRNewswire/ -- New England Biolabs (NEB®), a leading supplier of reagents for the life sciences, today announced the launch of a web-based tool for monitoring the emergence of SARS-CoV-2 variants and their potential impact on COVID-19 diagnostic tests. The Primer ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$302.5M98210%N/A
#2
$405.6M9996%N/A
#3
$394.6M11148%N/A
#4
$424.1M112222%N/A
#5
$300M48178%N/A